购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-51 (Compound 82) 作为一种羟基固醇17β-脱氢酶13 (HSD17B13) 的抑制剂,对雌二醇表现出不超过0.1 μM的IC50值。这种化合物常被应用于研究肝病、代谢性疾病或心血管疾病,例如NAFLD、NASH或药物性肝损伤(DILI)。
HSD17B13-IN-51 (Compound 82) 作为一种羟基固醇17β-脱氢酶13 (HSD17B13) 的抑制剂,对雌二醇表现出不超过0.1 μM的IC50值。这种化合物常被应用于研究肝病、代谢性疾病或心血管疾病,例如NAFLD、NASH或药物性肝损伤(DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-51 (Compound 82), an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibits potent activity with an IC50 value of ≤ 0.1 μM against estradiol. This compound is useful in researching various conditions including liver, metabolic, and cardiovascular diseases—specifically NAFLD, NASH, and drug-induced liver injury (DILI) [1]. |
分子量 | 509.26 |
分子式 | C22H13Cl2F3N4O3 |
CAS No. | 2770246-75-6 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.